In-vitro model to mimic T cell subset change in human PDAC organoid co-culture

Area of Science:

• Oncology
• Immunology
• Translational Medicine

Background:

• Immunotherapy has shown limited success in treating pancreatic ductal adenocarcinoma (PDAC).
• Personalized treatment strategies are crucial for advancing PDAC therapy.
• Understanding tumor-immune cell interactions is key to developing effective treatments.

Purpose of the Study:

• To model interactions between primary human PDAC organoids and matched peripheral blood mononuclear cells (PBMCs).
• To investigate T cell subtype dynamics in a co-culture system.
• To establish a preclinical platform for personalized PDAC treatment.

Main Methods:

• Co-culture of patient-derived PDAC organoids with autologous PBMCs.
• Flow cytometry analysis of T cell populations (CD4+, CD8+, Treg).
• Correlation of immune response in vitro with clinical outcomes.

Main Results:

• Co-culturing PDAC organoids with PBMCs induced changes in CD4+, CD8+, and Treg cell populations.
• A significant correlation was observed between PBMC reactivity in co-culture and favorable clinical outcomes in patients.
• The study demonstrates the feasibility of modeling patient-specific tumor-immune interactions.

Conclusions:

• The developed co-culture model effectively recapitulates PDAC-PBMC interactions.
• This system serves as a promising preclinical platform for evaluating personalized therapeutic strategies in PDAC.
• Findings support the potential of using in vitro immune responses to predict patient outcomes.